Back to Directory

Thomas Kakuda

Email

tkakuda@tibus.jnj.com

Phone

(650) 592-0962

Institution

Tibotec Inc.

Title

Director, Clinical Pharmacology

Address

Abbott Laboratories
338 Turks Head Lane
Redwood City, CA 94065
United States of America

Request an Update

Affiliated Studies

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

IMPAACT 2017: MOCHA

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2040: Phase I/II Study of the Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women with HIV-1

DAIDS Number

Research Area

Study Status